CreativeOne Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Sell
28,296
-1,727
-6% -$228K 0.08% 249
2026
Q1
$4.18M Sell
30,023
-647
-2% -$90.6K 0.1% 197
2025
Q4
$3.76M Buy
30,670
+766
+3% +$93.1K 0.09% 205
2025
Q3
$3.32M Sell
29,904
-1,884
-6% -$214K 0.08% 227
2025
Q2
$3.52M Buy
31,788
+2,257
+8% +$240K 0.09% 207
2025
Q1
$3.31M Sell
29,531
-11,709
-28% -$1.21M 0.1% 197
2024
Q4
$3.81M Buy
41,240
+9,105
+28% +$820K 0.12% 164
2024
Q3
$2.69M Buy
32,135
+9,352
+41% +$714K 0.09% 215
2024
Q2
$1.56M Sell
22,783
-871
-4% -$58.1K 0.08% 230
2024
Q1
$1.73M Buy
23,654
+9,875
+72% +$759K 0.07% 255
2023
Q4
$1.12M Sell
13,779
-3,937
-22% -$306K 0.07% 234
2023
Q3
$1.33M Sell
17,716
-1,293
-7% -$99.5K 0.1% 195
2023
Q2
$1.47M Buy
19,009
+3,780
+25% +$301K 0.07% 258
2023
Q1
$1.26M Buy
15,229
+4,947
+48% +$410K 0.06% 265
2022
Q4
$883K Sell
10,282
-5,880
-36% -$466K 0.05% 304
2022
Q3
$997K Buy
16,162
+12,335
+322% +$778K 0.06% 261
2022
Q2
$237K Sell
3,827
-657
-15% -$40.7K 0.01% 625
2022
Q1
$267K Sell
4,484
-801
-15% -$51.2K 0.01% 615
2021
Q4
$384K Sell
5,285
-2,070
-28% -$143K 0.02% 520
2021
Q3
$514K Buy
7,355
+604
+9% +$42.4K 0.03% 398
2021
Q2
$465K Sell
6,751
-5,663
-46% -$378K 0.03% 396
2021
Q1
$802K Sell
12,414
-2,953
-19% -$190K 0.06% 237
2020
Q4
$895K Buy
+15,367
New +$927K 0.07% 194

Other funds holding GILD

CreativeOne Wealth's GILD Position: Q2 2026 in Review

CreativeOne Wealth reduced its Gilead Sciences (GILD) stake by 5.8% in Q2 2026, selling an estimated $228K and leaving 28,296 shares worth $3.57M. The position accounts for 0.08% of the portfolio, ranked #249.

CreativeOne Wealth first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.18M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CreativeOne Wealth held 28,296 shares of Gilead Sciences worth $3.57M as of Q2 2026.
  • CreativeOne Wealth sold 1,727 Gilead Sciences shares in Q2 2026, an estimated $228K.
  • Gilead Sciences made up 0.08% of CreativeOne Wealth's portfolio in Q2 2026, its #249 holding.
  • CreativeOne Wealth first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • CreativeOne Wealth's Gilead Sciences position peaked at $4.18M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.